IBDEI1V2 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32755,1,3,0)
 ;;=3^Malig Neop Left Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,32755,1,4,0)
 ;;=4^C50.912
 ;;^UTILITY(U,$J,358.3,32755,2)
 ;;=^5001196
 ;;^UTILITY(U,$J,358.3,32756,0)
 ;;=C50.911^^182^1992^146
 ;;^UTILITY(U,$J,358.3,32756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32756,1,3,0)
 ;;=3^Malig Neop Right Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,32756,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,32756,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,32757,0)
 ;;=C50.919^^182^1992^118
 ;;^UTILITY(U,$J,358.3,32757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32757,1,3,0)
 ;;=3^Malig Neop Female Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,32757,1,4,0)
 ;;=4^C50.919
 ;;^UTILITY(U,$J,358.3,32757,2)
 ;;=^5001197
 ;;^UTILITY(U,$J,358.3,32758,0)
 ;;=C62.90^^182^1992^153
 ;;^UTILITY(U,$J,358.3,32758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32758,1,3,0)
 ;;=3^Malig Neop Testis,Unspec
 ;;^UTILITY(U,$J,358.3,32758,1,4,0)
 ;;=4^C62.90
 ;;^UTILITY(U,$J,358.3,32758,2)
 ;;=^5001236
 ;;^UTILITY(U,$J,358.3,32759,0)
 ;;=D03.9^^182^1992^155
 ;;^UTILITY(U,$J,358.3,32759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32759,1,3,0)
 ;;=3^Melanoma in Situ,Unspec
 ;;^UTILITY(U,$J,358.3,32759,1,4,0)
 ;;=4^D03.9
 ;;^UTILITY(U,$J,358.3,32759,2)
 ;;=^5001908
 ;;^UTILITY(U,$J,358.3,32760,0)
 ;;=C45.0^^182^1992^156
 ;;^UTILITY(U,$J,358.3,32760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32760,1,3,0)
 ;;=3^Mesothelioma of Pleura
 ;;^UTILITY(U,$J,358.3,32760,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,32760,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,32761,0)
 ;;=C90.01^^182^1992^157
 ;;^UTILITY(U,$J,358.3,32761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32761,1,3,0)
 ;;=3^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,32761,1,4,0)
 ;;=4^C90.01
 ;;^UTILITY(U,$J,358.3,32761,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,32762,0)
 ;;=C90.00^^182^1992^158
 ;;^UTILITY(U,$J,358.3,32762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32762,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,32762,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,32762,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,32763,0)
 ;;=C94.6^^182^1992^159
 ;;^UTILITY(U,$J,358.3,32763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32763,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,32763,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,32763,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,32764,0)
 ;;=D61.82^^182^1992^160
 ;;^UTILITY(U,$J,358.3,32764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32764,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,32764,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,32764,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,32765,0)
 ;;=D47.9^^182^1992^161
 ;;^UTILITY(U,$J,358.3,32765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32765,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,32765,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,32765,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,32766,0)
 ;;=D53.9^^182^1992^165
 ;;^UTILITY(U,$J,358.3,32766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32766,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,32766,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,32766,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,32767,0)
 ;;=D47.4^^182^1992^166
 ;;^UTILITY(U,$J,358.3,32767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32767,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,32767,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,32767,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,32768,0)
 ;;=D59.1^^182^1992^25
 ;;^UTILITY(U,$J,358.3,32768,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1V2
